Hosted by Joan Massagué, PhD, Chief Scientific Officer, Director of the Sloan Kettering Institute (SKI), and Marie-Josée and Henry R. Kravis Chair; Scott Stuart, Chair of the MSK Board of Trustees; and Marie-Josée Kravis, Vice Chair of the MSK Board.
This event will highlight Plasticity and Drug Resistance. The seminar will feature MSK thoracic oncologist Charles Rudin, MD, PhD, and cancer biologist Scott Lowe, PhD.
February 13, 2024
8 a.m. ET
Inquiries: contact mskgivingevents@mskcc.org or 646-227-3529